Immunotherapy pioneer Jim Allison honored with Sjöberg, Wolf and...
International recognition continues to accumulate for Jim Allison, Ph.D., for opening up an entirely new way to treat cancer by...
Can gut bacteria affect cancer’s response to immunotherapy?
Melanoma patients’ response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential...
Loss of tumor suppressor allows triple-negative breast...
When triple-negative breast cancer is still in its earliest, pre-cancerous stages, the tumor suppressor miRNA-29c becomes...
Scientists identify aggressive pancreatic cancer cells and their...
Researchers have identified a gatekeeper protein that prevents pancreatic cancer cells from transitioning into a particularly...
Chemotherapy may not be necessary for early-stage breast...
A new study from MD Anderson finds that women with early-stage breast cancer who had an intermediate risk recurrence score (RS)...
Trio of biomarkers could boost early detection of...
Adding two blood-borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for...
A new way to kill lung cancer with little collateral damage
Next-generation cyclin dependent kinase 2/9 (CDK2/9) inhibitors offer a new way to kill lung cancer while doing minimal harm to normal...
Gene may promote formation of breast, prostate tumors
UBE20, a gene found on chromosome 17, may play a role in breast and prostate tumor formation, MD Anderson researchers found in a...
Hormone therapy shows big promise for ovarian cancer...
For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma (LGSC), hormone...
Staining technique predicts breast cancer recurrence
Cyclin E, a protein important for DNA replication, is present in various forms of cancer in high levels. Overexpression of cyclin E...